Learn more

ABT HOLDING CO

Overview
  • Total Patents
    184
  • GoodIP Patent Rank
    22,898
  • Filing trend
    ⇧ 83.0%
About

ABT HOLDING CO has a total of 184 patent applications. It increased the IP activity by 83.0%. Its first patent ever was published in 1996. It filed its patents most often in Japan, United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are RIBOMIC INC, STEMBIOS TECHNOLOGIES INC and FUWAN PTY LTD.

Patent filings per year

Chart showing ABT HOLDING COs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Mays Robert W 28
#2 Woda Juliana Megan 24
#3 Ting Anthony E 21
#4 Verfaillie Catherine M 18
#5 Furcht Leo T 17
#6 Van T Hof Wouter 17
#7 Reyes Morayma 16
#8 Deans Robert J 15
#9 Harrington John 14
#10 Lehman Nicholas A 13

Latest patents

Publication Filing date Title
WO2020231941A1 Apparatus and method for cryostorage and manipulation of a plurality of container units
US2020246390A1 Multipotent adult projenitor cells for treatment of ich
AU2016256806A1 Modulation of angiogenesis
AU2016203976A1 Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
SG10201914102UA Stem cells for wound healing
WO2017062035A1 Methods for enhancing proliferation of t regulatory cells
AU2015202292A1 Modulation of macrophage activation
AU2014280897A1 Use of stem cells to prevent neuronal dieback
AU2014250727A1 Modulation of angiogenesis
US2014275035A1 Thienylindole azepines as serotonin 5-HT2C receptor ligands and uses thereof
BR112015014674A2 benzazepines as 5-ht2c serotonin receptor ligands and uses thereof
AU2013273625A1 Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
AU2013237687A1 Use of stem cells to reduce leukocyte extravasation
AU2013231210A1 Use of stem cells to reduce leukocyte extravasation
AU2011203281A1 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
WO2011143411A1 Modulation of splenocytes in cell therapy for traumatic brain injury
SG10201913920PA Modulation of splenocytes in cell therapy
US2011206647A1 Modulation of Angiogenesis
WO2011106476A1 Modulation of microglia activation
SG10201501402UA Modulation of macrophage activation